FINWIRES · TerminalLIVE
FINWIRES

EMVision Says Brain Scanner Clinical Study in South Australia to Show Ability to Provide Timely Stroke Diagnosis

By

EMVision Medical Devices (ASX:EMV) said a clinical study in South Australian regional hospitals will be conducted with its emu bedside brain scanner to demonstrate the ability to provide more timely stroke diagnosis, according to a Thursday Australian bourse filing.

The study will be conducted under a project funded by the Australian Government's Cooperative Research Centres Projects (CRC-P). A CRC-P progress payment of AU$337,425 was received in August.

The study targets regional and remote hospitals without ready on site-computed tomography access.

Site visits were completed, and protocol and ethics preparation are well advanced. Next steps include protocol finalisation, ethics approval, site contracting, and research governance approvals.

Its shares were up 1% in recent trading on Thursday.

Related Articles

Asia

Western Mining Subsidiary to Donate to Tibet Mudslide Victims

Western Mining (SHA:601168) subsidiary Tibet Yulong Copper donated 10 million yuan for mudslide victims in Gyirong County in Tibet, according to a Wednesday filing with the Shanghai bourse.The donation will come from the subsidiary's own funds.Company shares fell 2% during the midday break on Wednesday.

SHA:601168
Asia

Gunkul Engineering Names CFO

Gunkul Engineering (SET:GUNKUL) has appointed Thitawat Asaves as the chief financial officer of the company with effect from Tuesday, according to a same-day filing to the Thai stock exchange.The renewable energy company's shares were down nearly 1% in Wednesday's trade.He takes over from acting CFO Naruechon Dhumrongpiyawut, who resigned from the position effective Aug. 31.

SET:GUNKUL
Asia

Viva Goods Ups Stake in Sportswear Giant Li Ning

Viva Goods (HKG:0933) has purchased 29.6 million shares of Chinese sportswear giant Li Ning (HKG:2331) for HK$398.4 million as an investment, according to a Tuesday bourse filing.The company said it bought the shares through open market transactions at an average price of HK$13.45 apiece.Following the transaction, Viva's stakeholding in Li Ning rose to 16.9%, with ownership of 437.2 million shares.

HKG:0933HKG:2331